CCAAT/enhancer-binding proteins and the pathogenesis of retrovirus infection

Future Microbiology

Volumn 4, Issue 3, 2009, Pages 299-321

  Liu, Yujie ^a   Nonnemacher, Michael R ^a   Wigdahl, Brian ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

CCAAT enhancer binding protein; Gene expression; HIV 1; Human T cell leukemia virus type 1; Retrovirus; SIV; Transcription

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR; BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; CCAAT ENHANCER BINDING PROTEIN; CCAAT ENHANCER BINDING PROTEIN ALPHA; CCAAT ENHANCER BINDING PROTEIN BETA; CCAAT ENHANCER BINDING PROTEIN BETA 1; CCAAT ENHANCER BINDING PROTEIN BETA 2; CCAAT ENHANCER BINDING PROTEIN DELTA; CCAAT ENHANCER BINDING PROTEIN EPSILON; CHEMOKINE; CHEMOKINE RECEPTOR CCR5; CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 12; INTERLEUKIN 1BETA; MESSENGER RNA; PROTEIN P50; PROTEIN SWI; RAD51 PROTEIN; SYNAPTOTAGMIN I; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SNF; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VPR PROTEIN; ISOPROTEIN;

BINDING SITE; BRAIN; CARBOXY TERMINAL SEQUENCE; CHROMATIN ASSEMBLY AND DISASSEMBLY; GENE EXPRESSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN T CELL LEUKEMIA VIRUS 1; LONG TERMINAL REPEAT; LUNG; MACROPHAGE; MONOCYTE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; RETROVIRUS; RETROVIRUS INFECTION; REVIEW; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE; TRANSCRIPTION REGULATION; VIRUS TRANSCRIPTION; ANIMAL; BIOSYNTHESIS; CHEMISTRY; ENHANCER REGION; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T CELL LEUKEMIA VIRUS INFECTION; METABOLISM; MONKEY DISEASE; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; TRANSCRIPTION INITIATION; VIRUS REPLICATION;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 1; SIMIAN IMMUNODEFICIENCY VIRUS;

ANIMALS; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CHEMOKINES; ENHANCER ELEMENTS, GENETIC; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, VIRAL; HIV INFECTIONS; HIV-1; HTLV-I INFECTIONS; HUMANS; PROTEIN ISOFORMS; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, CCR5; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; TRANSCRIPTIONAL ACTIVATION; VIRUS REPLICATION;

EID: 65549140316     PISSN: 17460913     EISSN: None     Source Type: Journal    
DOI: 10.2217/fmb.09.4     Document Type: Review

References (194)

1. Cao Z, Umek RM, McKnight SL: Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev. 5, 1538-1552 (1991).
2. Akira S, Isshiki H, Sugita T et al.: A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J. 9, 1897-1906 (1990).
3. Chang CJ, Chen TT, Lei HY, Chen DS, Lee SC: Molecular cloning of a transcription factor, AGP/EBP, that belongs to members of the C/EBP family. Mol. Cell. Biol. 10, 6642-6653 (1990).
4. Poli V, Mancini FP, Cortese R: IL-6DBP, a nuclear protein involved in interleukin-6 signal transduction, defines a new family of leucine zipper proteins related to C/EBP. Cell 63, 643-653 (1990).
5. Pei DQ, Shih CH: An "attenuator domain" is sandwiched by two distinct transactivation domains in the transcription factor C/EBP. Mol. Cell. Biol. 11, 1480-1487 (1991).
6. Kowenz-Leutz E, Twamley G, Ansieau S, Leutz A: Novel mechanism of C/ EBPβ (NF-M) transcriptional control: activation through derepression. Genes Dev. 8, 2781-2791 (1994).
7. Antonson P, Stellari B, Yamanaka R, Xanthopoulos KG: A novel human CCAAT/ enhancer binding protein gene, C/EBP,̇is expressed in cells of lymphoid and myeloid lineages and is localized on chromosome 14q11.2 close to the T-cell receptor α/δ locus. Genomics 35, 30-38 (1996).
8. Wang XZ, Ron D: Stress-induced phosphorylation and activation of the transcription factor CHOP (GADD153) by p38 MAP Kinase. Science 272, 1347-1349 (1996).
9. Ron D, Habener JF: CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription. Genes Dev. 6, 439-453 (1992).
10. Yamanaka R, Kim GD, Radomska HS et al.: CCAAT/enhancer binding protein ̇is preferentially up-regulated during granulocytic differentiation and its functional versatility is determined by alternative use of promoters and differential splicing. Proc. Natl Acad. Sci. USA 94, 6462-6467 (1997).
11. Cooper C, Henderson A, Artandi S, Avitahl N, Calame K: Ig/EBP (C/ EBPγ) is a transdominant negative inhibitor of C/EBP family transcriptional activators. Nucleic Acids Res. 23, 4371-4377 (1995).
12. Descombes P, Schibler U: A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA. Cell 67, 569-579 (1991).
13. Ossipow V, Descombes P, Schibler U: CCAAT/enhancer-binding protein mRNA is translated into multiple proteins with different transcription activation potentials. Proc. Natl Acad. Sci. USA 90, 8219-8223 (1993).
14. Ramji DP, Foka P: CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem. J. 365, 561-575 (2002).
15. Ross SE, Radomska HS, Wu B et al.: Phosphorylation of C/EBPα inhibits granulopoiesis. Mol. Cell. Biol. 24, 675-686 (2004).
16. Arizmendi C, Liu S, Croniger C, Poli V, Friedman JE: The transcription factor CCAAT/enhancer-binding protein β regulates gluconeogenesis and phosphoenolpyruvate carboxykinase (GTP) gene transcription during diabetes. J. Biol. Chem. 274, 13033-13040 (1999).
17. Darlington GJ, Ross SE, MacDougald OA: The role of C/EBP genes in adipocyte differentiation. J. Biol. Chem. 273, 30057-30060 (1998).
18. Hu HM, Baer M, Williams SC, Johnson PF, Schwartz RC: Redundancy of C/ EBP-α, -β, and -δ in supporting the lipopolysaccharide-induced transcription of IL-6 and monocyte chemoattractant protein-1. J. Immunol. 160, 2334-2342 (1998).
19. Cloutier A, Guindi C, Larivee P et al.: Inflammatory cytokine production by human neutrophils involves C/EBP transcription factors. J. Immunol. 182, 563-571 (2009).
20. Hu HM, Tian Q, Baer M et al.: The C/EBP bZIP domain can mediate lipopolysaccharide induction of the proinflammatory cytokines interleukin-6 and monocyte chemoattractant protein-1. J. Biol. Chem. 275, 16373-16381 (2000).
21. Gao H, Parkin S, Johnson PF, Schwartz RC: C/EBPγ has a stimulatory role on the IL-6 and IL-8 promoters. J. Biol. Chem. 277, 38827-38837 (2002).
22. Scott LM, Civin CI, Rorth P, Friedman AD: A novel temporal expression pattern of three C/EBP family members in differentiating myelomonocytic cells. Blood 80, 1725-1735 (1992).
23. Henderson AJ, Zou X, Calame KL: C/EBP proteins activate transcription from the human immunodeficiency virus type-1 long terminal repeat in macrophages/monocytes. J. Virol. 69, 5337-5344 (1995).
24. Tengku-Muhammad TS, Hughes TR, Ranki H, Cryer A, Ramji DP: Differential regulation of macrophage CCAAT-enhancer binding protein isoforms by lipopolysaccharide and cytokines. Cytokine 12, 1430-1436 (2000).
25. Dowell P, Lane MD: C/EBPα reverses the anti-adipogenic effects of the HIV protease inhibitor nelfinavir. Biochem. Biophys. Res. Commun. 327, 571-574 (2005).
26. El Hadri K, Glorian M, Monsempes C et al.: In vitro suppression of the lipogenic pathway by the nonnucleoside reverse transcriptase inhibitor efavirenz in 3T3 and human preadipocytes or adipocytes. J. Biol. Chem. 279, 15130-15141 (2004).
27. Dowell P, Flexner C, Kwiterovich PO, Lane MD: Suppression of preadipocyte differentiation and promotion of adipocyte death by HIV protease inhibitors. J. Biol. Chem. 275, 41325-41332 (2000).
28. Bradley MN, Zhou L, Smale ST: C/EBPβ regulation in lipopolysaccharide-stimulated macrophages. Mol. Cell. Biol. 23, 4841-4858 (2003).
29. Natsuka S, Akira S, Nishio Y et al.: Macrophage differentiation-specific expression of NF-IL6, a transcription factor for interleukin-6. Blood 79, 460-466 (1992).
30. Williams SC, Baer M, Dillner AJ, Johnson PF: CRP2 (C/EBPβ) contains a bipartite regulatory domain that controls transcriptional activation, DNA binding and cell specificity. EMBO J. 14, 3170-3183 (1995).
31. Takiguchi M: The C/EBP family of transcription factors in the liver and other organs. Int. J. Exp. Pathol. 79, 369-391 (1998).
32. Grimm SL, Rosen JM: The role of C/EBPβ in mammary gland development and breast cancer. J. Mammary Gland Biol. Neoplasia 8, 191-204 (2003).
33. Chinery R, Brockman JA, Dransfield DT, Coffey RJ: Antioxidant-induced nuclear translocation of CCAAT/enhancer-binding protein β. A critical role for protein kinase A-mediated phosphorylation of Ser299. J. Biol. Chem. 272, 30356-30361 (1997).
34. Nakajima T, Kinoshita S, Sasagawa T et al.: Phosphorylation at threonine-235 by a ras-dependent mitogen-activated protein kinase cascade is essential for transcription factor NF-IL6. Proc. Natl Acad. Sci. USA 90, 2207-2211 (1993).
35. Pham TH, Langmann S, Schwarzfischer L et al.: CCAAT enhancer-bindihg protein β regulates constitutive gene expression during. late stages of monocyte to macrophage differentiation. J. Biol. Chem. 282, 21924-21933 (2007).
36. Mameli G, Deshmane SL, Ghafouri M et al.: C/EBPβ regulates human immunodeficiency virus 1 gene expression through its association with cdk9. J. Gen. Virol. 88, 631-640 (2007).
37. Williams SC, Cantwell CA, Johnson PF: A family of C/EBP-related proteins capable of forming covalently linked leucine zipper dimers in vitro. Genes Dev. 5, 1553-1567 (1991).
38. Nye JA, Graves BJ: Alkylation interference identifies essential DNA contacts for sequence-specific binding of the eukaryotic transcription factor C/EBP. Proc. Natl Acad. Sci. USA 87, 3992-3996 (1990).
39. Hendricks-Taylor LR, Bachinski LL, Siciliano MJ et al.: The CCAAT/ enhancer binding protein (C/EBPα) gene (CEBPA) maps to human chromosome 19q13.1 and the related nuclear factor NF-IL6 (C/EBPβ) gene (CEBPB) maps to human chromosome 20q13.1. Genomics 14, 12-17 (1992).
40. Jenkins NA, Gilbert DJ, Cho BC et al.: Mouse chromosomal location of the CCAAT/enhancer binding proteins C/EBPβ (Cebpb), C/EBPδ (Cebpd), and CRP1 (Cebpe). Genomics 28, 333-336 (1995).
41. Descombes P, Chojkier M, Lichtsteiner S, Falvey E, Schibler U: LAP, a novel member of the C/EBP gene family, encodes a liver-enriched transcriptional activator protein. Genes Dev. 4, 1541-1551 (1990).
42. Baer M, Johnson PF: Generation of truncated C/EBPβ isoforms by in vitro proteolysis. J. Biol. Chem. 275, 26582-26590 (2000).
43. Baer M, Williams SC, Dillner A, Schwartz RC, Johnson PF: Autocrine signals control CCAAT/enhancer binding protein β expression, localization, and activity in macrophages. Blood 92, 4353-4365 (1998).
44. Welm AL, Timchenko NA, Darlington GJ: C/EBPα regulates generation of C/EBPβ isoforms through activation of specific proteolytic cleavage. Mol. Cell. Biol. 19, 1695-1704 (1999).
45. Wei W, Yang H, Cao P et al.: Degradation of C/EBPβ in cultured myotubes is calpain-dependent. J. Cell. Physiol. 208, 386-398 (2006).
46. Eaton EM, Hanlon M, Bundy L, Sealy L: Characterization of C/EBPβ isoforms in normal versus neoplastic mammary epithelial cells. J. Cell. Physiol. 189, 91-105 (2001).
47. Bundy LM, Sealy L: CCAAT/enhancer binding protein B (C/EBPβ)-2 transforms normal mammary epithelial cells and induces epithelial to mesenchymal transition in culture. Oncogene 22, 869-883 (2003).
48. Lee YM, Miau LH, Chang CJ, Lee SC: Transcriptional induction of the α-1 acid glycoprotein (AGP) gene by synergistic interaction of two alternative activator forms of AGP/enhancer-binding protein (C/EBPβ) and NF-κB or Nopp140. Mol. Cell. Biol. 16, 4257-4263 (1996).
49. Kowenz-Leutz E, Leutz A: A C/EBPβ isoform recruits the SWI/SNF complex to activate myeloid genes. Mol. Cell 4, 735-743 (1999).
50. Su WC, Chou HY, Chang CJ et al.: Differential activation of a C/ EBPβ isoform by a novel redox switch may confer the lipopolysaccharide-inducible expression of interleukin-6 gene. J. Biol. Chem. 278, 51150-51158 (2003).
51. Eaton EM, Sealy L: Modification of CCAAT/enhancer-binding protein-β by the small ubiquitin-like modifier (SUMO) family members, SUMO-2 and SUMO-3. J. Biol. Chem. 278, 33416-33421 (2003).
52. Hsu W, Chen-Kiang S: Convergent regulation of NF-IL6 and Oct-1 synthesis by interleukin-6 and retinoic acid signaling in embryonal carcinoma cells. Mol. Cell. Biol. 13, 2515-2523 (1993).
53. Tanaka N, Hoshino Y, Gold et al.: Interleukin-10 induces inhibitory C/EBPβ through STAT-3 and represses HIV-1 transcription in macrophages. Am. J. Respir. Cell Mol. Biol. 33, 406-411 (2005).
54. Tesmer VM, Bina M: Regulation of HIV-1 gene expression by NF-IL6. J. Mol. Biol. 262, 327-335 (1996).
55. Tesmer VM, Rajadhyaksha A, Babin J, Bina M: NF-IL6-mediated transcriptional activation of the long terminal repeat of the human immunodeficiency virus type 1. Proc. Natl Acad. Sci. USA 90, 7298-7302 (1993).
56. Henderson AJ, Connor RI, Calame KL: C/EBP activators are required for HIV-1 replication and proviral induction in monocytic cell lines. Immunity 5, 91-101 (1996).
57. Hogan TH, Krebs FC, Wigdahl B: Regulation of human immunodeficiency virus type 1 gene expression and pathogenesis by CCAAT/enhancer binding proteins in cells of the monocyte/macrophage lineage. J. Neurovirol. 8(Suppl. 2), 21-26 (2002).
58. Burdo TH, Gartner S, Mauger D, Wigdahl B: Region-specific distribution of human immunodeficiency virus type 1 long terminal repeats containing specific configurations of CCAAT/enhancer-binding protein site II in brains derived from demented and nondemented patients. J. Neurovirol. 10(Suppl. 1), 7-14 (2004).
59. Krebs FC, Hogan TH, Quiterio S, Gartner S, Wigdahl B: Lentiviral LTR-directed expression, sequence variation, and disease pathogenesis. In: HIV Sequence Compendium 2001. Kuiken C, Foley B, Hahn B et al. (Eds.). Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM, USA. LA-UR 02-2877 pp. 29-70 (2001).
60. Ross HL, Gartner S, McArthur JC et al.: HIV-1 LTR C/EBP-binding site sequence configurations preferentially encountered in brain lead to enhanced C/EBP factor binding and increased LTR-specific activity. J. Neurovirol. 7, 235-249 (2001).
61. Yang Y, Tesmer VM, Bina M: Regulation of HIV-1 transcription in activated monocyte macrophages. Virology 299, 256-265 (2002).
62. + T cells. Proc. Natl Acad. Sci. USA 94, 8714-8719 (1997).
63. Davydov IV, Krammer PH, Li-Weber M: Nuclear factor-IL6 activates the human IL-4 promoter in T cells. J. Immunol. 155, 5273-5279 (1995).
64. Berberich-Siebelt F, Berberich I, Andrulis M et al.: SUMOylation interferes with CCAAT/enhancer-binding protein-β-mediated c-myc repression, but not IL-4 activation in T cells. J. Immunol. 176, 4843-4851 (2006).
65. Rosati M, Valentin A, Patenaude DJ, Pavlakis GN: CCAAT-enhancer-binding protein-β (C/EBPβ) activates CCR5 promoter: increased C/ EBPβ and CCR5 in T lymphocytes from HIV-1-infected individuals. J. Immunol. 167, 1654-1662 (2001).
66. Buckner AE, Tesmer VM, Bina M: Regulation of HIV-1 transcription by NF-IL6 in activated Jurkat T cells. Virus Res. 89, 53-63 (2002).
67. Nerlov C, Ziff EB: CCAAT/enhancer binding protein-α amino acid motifs with dual TBP and TFIIB binding ability co-operate to activate transcription in both yeast and mammalian cells. EMBO J. 14, 4318-4328 (1995).
68. Pedersen TA, Kowenz-Leutz E, Leutz A, Nerlov C: Cooperation between C/ EBPα TBP/TFIIB and SWI/SNF recruiting domains is required for adipocyte differentiation. Genes Dev. 15, 3208-3216 (2001).
69. Dumais N, Bounou S, Olivier M, Tremblay MJ: Prostaglandin E (2)-mediated activation of HIV-1 long terminal repeat transcription in human T cells necessitates CCAAT/enhancer binding protein (C/EBP) binding sites in addition to cooperative interactions between C/EBPβ and cyclic adenosine 5′-monophosphate response element binding protein. J. Immunol. 168, 274-282 (2002).
70. Park EA, Gurney AL, Nizielski SE et al.: Relative roles of CCAAT/ enhancer-binding protein β and cAMP regulatory element-binding protein in controlling transcription of the gene for phosphoenolpyruvate carboxykinase (GTP). J. Biol. Chem. 268, 613-619 (1993).
71. Kinoshita SM, Taguchi S: NF-IL6 (C/EBPβ) induces HIV-1 replication by inhibiting cytidine deaminase APOBEC3G. Proc. Natl Acad. Sci. USA 105, 15022-15027 (2008).
72. Chiu YL, Greene WC: The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retroelements. Annu. Rev. Immunol. 26, 317-353 (2008).
73. Kramer-Hammerle S, Rothenaigner I, Wolff H, Bell JE, Brack-Werner R: Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus. Virus Res. 111, 194-213 (2005).
74. Ghafouri M, Amini S, Khalili K, Sawaya BE: HIV-1 associated dementia: symptoms and causes. Retrovirology 3, 28 (2006).
75. Ejarque-Ortiz A, Medina MG, Tusell JM et al.: Upregulation of CCAAT/enhancer binding protein β in activated astrocytes and microglia. Glia 55, 178-188 (2007).
76. Schwartz C, Catez P, Rohr O et al.: Functional interactions between C/EBP, Sp1, and COUP-TF regulate human immunodeficiency virus type 1 gene transcription in human brain cells. J. Virol. 74, 65-73 (2000).
77. Cardinaux JR, Allaman I, Magistretti PJ: Proinflammatory cytokines induce the transcription factors C/EBPβ and C/EBPδ in astrocytes. Glia 29, 91-97 (2000).
78. Honda Y, Rogers L, Nakata K et al.: Type I interferon induces inhibitory 16 kD CCAAT/enhancer binding protein (C/EBP)β, repressing the HIV-1 long terminal repeat in macrophages: pulmonary tuberculosis alters C/EBP expression, enhancing HIV-1 replication. J. Exp. Med. 188, 1255-1265. (1998).
79. Nakata K, Rom WN, Honda Y et al.: Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication in the lung. Am. J. Respir. Crit. Care Med. 155, 996-1003 (1997).
80. Wright JR: Immunomodulatory functions of surfactant. Physiol. Rev. 77, 931-962 (1997).
81. Gold JA, Hoshino Y, Tanaka N et al.: Surfactant protein A modulates the inflammatory response in macrophages during tuberculosis. Infect. Immun. 72, 645-650 (2004).
82. Hoshino Y, Nakata K, Hoshino S et al.: Maximal HIV-1 replication in alveolar macrophages during tuberculosis requires both lymphocyte contact and cytokines. J. Exp. Med. 195, 495-505 (2002).
83. Nakata K, Keicho N, Honda Y et al.: The mechanism of HIV replication at the site of inflammation coinfected with HIV and M. tuberculosis. Kekkaku 77, 687-692 (2002).
84. Emori Y, Ikeda T, Ohashi T et al.: Inhibition of human immunodeficiency virus type 1 replication by Z-100, an immunomodulator extracted from human-type tubercle bacilli, in macrophages. J. Gen. Virol. 85, 2603-2613 (2004).
85. Darcissac EC, Truong MJ, Dewulf J et al.: The synthetic immunomodulator murabutide controls human immunodeficiency virus type-1 replication at multiple levels in macrophages and dendritic cells. J. Virol. 74, 7794-7802 (2000).
86. Vidal VF, Casteran N, Riendeau CJ et al.: Macrophage stimulation with murabutide, an HlV-suppressive muramyl peptide derivative, selectively activates extracellular signal-regulated kinases 1 and 2, C/ EBPβ and STAT1: role of CD14 and Toll-like receptors 2 and 4. Eur. J. Immunol. 31, 1962-1971 (2001).
87. Komuro I, Yokota Y, Yasuda S, Iwamoto A, Kagawa KS: CSF-induced and HIV-1-mediated distinct regulation of Hck and C/EBPβ represent a heterogeneous susceptibility of monocyte-derived macrophages to M-tropic HIV-1 infection. J. Exp. Med. 198, 443-453 (2003).
88. Komuro I, Sunazuka T, Akagawa KS et al.: Erythromycin derivatives inhibit HIV-1 replication in macrophages through modulation of MAPK activity to induce small isoforms of C/EBPβ. Proc. Natl Acad. Sci. USA 105, 12509-12514 (2008).
89. Popik W, Hesselgesser JE, Pitha PM: Binding of human immunodeficiency virus type 1 to CD4 and CXCR4 receptors differentially regulates expression of inflammatory genes and activates the MEK/ERK signaling pathway. J. Virol. 72, 6406-6413 (1998).
90. Lee ES, Sarma D, Zhou H, Henderson AJ: CCAAT/enhancer binding proteins are not required for HIV-1 entry but regulate proviral transcription by recruiting coactivators to the long-terminal repeat in monocytic cells. Virolgy 299, 20-31 (2002).
91. Kuo MH, Allis CD: Roles of histone acetyltransferases and deacetylases in gene regulation. Bioessays 20, 615-626 (1998).
92. Mink S, Haenig B, Klempnauer KH: Interaction and functional collaboration of p300 and C/EBPβ. Mol. Cell. Biol. 17, 6609-6617 (1997).
93. Chakravarti D, Ogryzko V, Kao HY et al.: A viral mechanism for inhibition of p300 and PCAF acetyltransferase activity. Cell 96, 393-403 (1999).
94. Hamamori Y, Sartorelli V, Ogryzko V et al.: Regulation of histone acetyltransferases p300 and PCAF by the bHLH protein twist and adenoviral oncoprotein E1A. Cell 96, 405-413 (1999).
95. Schwartz C, Beck K, Mink S et al.: Recruitment of p300 by C/ EBPβ triggers phosphorylation of p300 and modulates coactivator activity. EMBO J. 22, 882-892 (2003).
96. So CW, van der Reijden BA: C/EBPα, do not forget your TIP60. Leukemia 22, 676-677 (2008).
97. Bararia D, Trivedi AK, Zada AA et al.: Proteomic identification of the MYST domain histone acetyltransferase TIP60 (HTATIP) as a co-activator of the myeloid transcription factor C/EBPα. Leukemia 22, 800-807 (2008).
98. Williams SA, Chen LF, Kwon HH et al.: NF-κB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation. EMBO J. 25, 139-149 (2006).
99. Ylisastigui L, Archin NM, Lehrman G, Bosch RJ, Margolis DM: Coaxing HIV-1 from resting CD4 T cells: histone deacetylase inhibition allows latent viral expression. AIDS 18, 1101-1108 (2004).
100. Jiang G, Espeseth A, Hazuda DJ, Margolis DM: c-Myc and Sp1 contribute to proviral latency by recruiting histone deacetylase 1 to the human immunodeficiency virus type 1 promoter. J. Virol. 81, 10914-10923 (2007).
101. Di-Poi N, Desvergne B, Michalik L, Wahli W: Transcriptional repression of peroxisome proliferator-activated receptor β/δ in murine keratinocytes by CCAAT/enhancer-binding proteins. J. Biol. Chem. 280, 38700-38710 (2005).
102. Wiper-Bergeron N, Wu D, Pope L, Schild-Poulter C, Hache RJ: Stimulation of preadipocyte differentiation by steroid through targeting of an HDAC1 complex. EMBO J. 22, 2135-2145 (2003).
103. Zuo Y, Qiang L, Farmer SR: Activation of CCAAT/enhancer-binding protein (C/EBP) α expression by C/EBPβ during adipogenesis requires a peroxisome proliferator-activated receptor-γ-associated repression of HDAC1 at the C/EBP α gene promoter. J. Biol. Chem. 281, 7960-7967 (2006).
104. Wiper-Bergeron N, Salem HA, Tomlinson JJ, Wu D, Hache RJ: Glucocorticoid-stimulated preadipocyte differentiation is mediated through acetylation of C/EBPβ by GCN5. Proc. Natl Acad. Sci. USA 104, 2703-2708 (2007).
105. Kurland JF, Tansey WP: Myc-mediated transcriptional repression by recruitment of histone deacetylase. Cancer Res. 68, 3624-3629 (2008).
106. Faiola F, Liu X, Lo S et al.: Dual regulation of c-Myc by p300 via acetylation-dependent control of Myc protein turnover and coactivation of Myc-induced transcription. Mol. Cell. Biol. 25, 10220-10234 (2005).
107. Vervoorts J, Luscher-Firzlaff JM, Rottmann S et al.: Stimulation of c-Myc transcriptional activity and acetylation by recruitment of the cofactor CBP. EMBO Rep. 4, 484-490 (2003).
108. Bachelerie F, Alcami J, Arenzana-Seisdedos F, Virelizier JL: HIV enhancer activity perpetuated by NF-κB induction on infection of monocytes. Nature 350, 709-712 (1991).
109. Alcami J, Lain de Lera T, Folgueira L et al.: Absolute dependence on κB responsive elements for initiation and Tat-mediated amplification of HIV transcription in blood CD4 T lymphocytes. EMBO J. 14, 1552-1560 (1995).
110. Nabel G, Baltimore D: An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature 326, 711-713 (1987).
111. Asin S, Bren GD, Carmona EM, Solan NJ, Paya CV: NF-κB cis-acting motifs of the human immunodeficiency virus (HIV) long terminal repeat regulate HIV transcription in human macrophages. J. Virol. 75, 11408-11416 (2001).
112. Srein B, Cogswell PC, Baldwin AS Jr.: Functional and physical associations between NF-κB and C/EBP family members: a Rel domain-bZIP interaction. Mol. Cell. Biol. 13, 3964-3974 (1993).
113. Ruocco MR, Chen X, Ambrosino C et al.: Regulation of HIV-1 long terminal repeats by interaction of C/EBP (NF-IL6) and NF-κB/Rel transcription factors. J. Biol. Chem. 271, 22479-22486 (1996).
114. Mukerjee R, Sawaya BE, Khalili K, Amini S: Association of p65 and C/ EBPβ with HIV-1 LTR modulates transcription of the viral promoter. J. Cell Biochem. 100, 1210-1216 (2007).
115. Abraham S, Sweet T, Sawaya BE et al.: Cooperative interaction of C/EBPβ and Tat modulates MCP-1 gene transcription in astrocytes. J. Neuroimmunol. 160, 219-227 (2005).
116. Krebs FC, Goodenow MM, Wigdahl B: Neuroglial ATF/CREB factors interact with the human immunodeficiency virus type 1 long terminal repeat. J. Neurovirol. 3(Suppl. 1), S28-S32 (1997).
117. Ross HL, Nonnemacher MR, Hogan TH et al.: Interaction between CCAAT/enhancer binding protein and cyclic AMP response element binding protein 1 regulates human immunodeficiency virus type 1 transcription in cells of the monocyte/macrophage lineage. J. Virol. 75, 1842-1856 (2001).
118. Aten JA, Stap J, Krawczyk PM et al.: Dynamics of DNA double-strand breaks revealed by clustering of damaged chromosome domains. Science 303, 92-95 (2004).
119. Chipitsyna G, Slonina D, Siddiqui K et al.: HIV-1 Tat increases cell survival in response to cisplatin by stimulating Rad51 gene expression. Oncogene 23, 2664-2671 (2004).
120. Chipitsyna G, Sawaya BE, Khalili K, Amini S: Cooperativity between Rad51 and C/EBP family transcription factors modulates basal and Tat-induced activation of the HIV-1 LTR in astrocytes. J. Cell. Physiol. 207, 605-613 (2006).
121. Liou LY, Herrmann CH, Rice AP: HIV-1 infection and regulation of Tat function in macrophages. Int. J. Biochem. Cell Biol. 36, 1767-1775 (2004).
122. Brady J, Kashanchi F: Tat gets the "green" light on transcription initiation. Retrovirology 2, 69 (2005).
123. Huigen MC, Kamp W, Nottet HS: Multiple effects of HIV-1 trans-activator protein on the pathogenesis of HIV-1 infection. Eur. J. Clin. Invest. 34, 57-66 (2004).
124. Ambrosino C, Ruocco MR, Chen X et al.: HIV-1 Tat induces the expression of the interleukin-6 (IL6) gene by binding to the IL6 leader RNA and by interacting with CAAT enhancr-binding protein β (NF-IL6) transcription factors. J. Biol. Chem. 272, 14883-14892 (1997).
125. Mukerjee R, Sawaya BE, Khalili K, Amini S: Association of p65 and C/ EBPβ with HIV-1 LTR modulates transcription of the viral promoter. J. Cell Biochem. 100(5), 1210-1216 (2006).
126. Liu X, Jana M, Dasgupta S et al.: Human immunodeficiency virus type 1 (HIV-1) tat induces nitric-oxide synthase in human astroglia. J. Biol. Chem. 277, 39312-39319 (2002).
127. Hori K, Hatfield D, Maldarelli F, Lee BJ, Clouse KA: Selenium supplementation suppresses tumor necrosis factor α-induced human immunodeficiency virus type 1 replication in vitro. AIDS Res. Hum. Retroviruses 13, 1325-1332 (1997).
128. Adamson DC, Wildemann B, Sasaki M et al.: Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41. Science 274, 1917-1921 (1996).
129. Johnson MD, Kim P, Tourtellotte W, Federspiel CF: Transforming growth factor-β and monocyte chemotactin protein-1 are elevated in cerebrospinal fluid of immunocompromised patients with HIV-1 infection. J. NeuroAIDS 2, 33-43 (2004).
130. Conant K, Garzino-Demo A, Nath A et al.: Induction of monoeyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. Proc. Natl Acad. Sci. USA 95, 3117-3121 (1998).
131. Mengozzi M, De Filippi C, Transidico P et al.: Human immunodeficiency virus replication induces monocyte chemotactic protein-1 in human macrophages and U-937 promonocytic cells. Blood, 1851-1857 (1999).
132. Wiley CA, Schrier RD, Nelson JA, Lampert PW, Oldstone MB: Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc. Natl Acad. Sci. USA 83, 7089-7093 (1986).
133. King JE, Eugenin EA, Buckner CM, Berman JW: HIV tat and neurotoxicity. Microbes Infect. 8, 1347-1357 (2006).
134. Peruzzi F, Gordon J, Darbinian N, Amini S: Tat-induced deregulation of neuronal differentiation and survival by nerve growth factor pathway. J. Neurovirol. 8(Suppl. 2), 91-96 (2002).
135. Haughey NJ, Mattson MP: Calcium dysregulation and neuronal apoptosis by the HIV-1 proteins Tat and gp120. J. Acquir. Immune Defic. Syndr., 31(Suppl. 2), S55-S61 (2002).
136. Li L, Li HS, Pauza CD, Bukrinsky M, Zhao RY: Roles of HIV-1 auxiliary proteins in viral pathogenesis and host-pathogen interactions. Cell Res. 15, 923-934 (2005).
137. Andersen JL, Planelles V: The role of Vpr in HIV-1 pathogenesis. Curr. HIV Res. 3, 43-51 (2005).
138. Kino T, Pavlakis GN: Partner molecules of accessory protein Vpr of the human immunodeficiency virus type 1. DNA Cell Biol. 23, 193-205 (2004).
139. Philippon V, Matsuda Z, Essex M: Transactivaticn is a conserved function among primate lentivirus Vpr proteins but is not shared by Vpx. J. Hum. Virol. 2, 167-174 (1999).
140. Sawaya BE, Khalili K, Rappaport J et al.: Suppression of HIV-1 transcription and replication by a Vpr mutant. Gene Ther. 6, 947-950 (1999).
141. Wang L, Mukherjee S, Jia F, Narayan O, Zhao LJ: Interaction of virion protein Vpr of human immunodeficiency virus type 1 with cellular transcription factor Sp1 and trans activation of viral long terminal repeat. J. Biol. Chem. 270, 25564-25569 (1995).
142. Zhang S, Pointer D, Singer G et al.: Direct binding to nucleic acids by Vpr of human immunodeficiency virus type 1. Gene 212, 157-166 (1998).
143. Hogan TH, Nonnemacher MR, Krebs FC, Henderson A, Wigdahl B: HIV-1 Vpr binding to HIV-1 LTR C/EBP cis-acting elements and adjacent regions is sequence-specific. Biomed. Pharmacother. 57, 41-48 (2003).
144. Burdo TH, Nonnemacher M, Irish BP et al.: High-affinity interaction between HIV-1 Vpr and specific sequences that span the C/EBP and adjacent NF-κB sites within the HIV-1 LTR correlate with HIV-1-associated dementia. DNA Cell Biol. 23, 261-269 (2004).
145. Roux P, Alfieri C, Hrimech M, Cohen EA, Tanner JE: Activation of transcription factors NF-κB and NF-IL-6 by human immunodeficiency virus type 1 protein R (Vpr) induces interleukin-8 expression. J. Virol. 74, 4658-4665 (2000).
146. Tyor WR, Glass JD, Griffin JW et al.: Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann. Neurol. 31, 349-360 (1992).
147. Kedzierska K, Crowe SM: Cytokines and HIV-1: interactions and clinical implications. Antivir. Chem. Chemother. 12, 133-150 (2001).
148. Screpanti I, Romani L, Musiani P et al.: Lymphoproliferative disorder and imbalanced T-helper response in C/EBPP-deficient mice. EMBO J. 14, 1932-1941 (1995).
149. Gorgoni B, Maritano D, Marthyn P, Righi M, Poli V: C/EBPβ gene inactivation causes both impaired and enhanced gene expression and inverse regulation of IL-12 p40 and p35 mRNAs in macrophages. J. Immunol. 168, 4055-4062 (2002).
150. Akira S, Kishimoto T: IL-6 and NF-IL6 in acute-phase response and viral infection. Immunol. Rev. 127, 25-50 (1992).
151. Hungness ES, Luo GJ, Pritts TA et al.: Transcription factors C/ EBP-β and -δ regulate IL-6 production in IL-1β-stimulated human enterocytes. J. Cell. Physiol. 192, 64-70 (2002).
152. Shirakawa F, Saito K, Bonagura CA et al.: The human prointerleukin-1β gene requires DNA sequences both proximal and distal to the transcription start site for tissue-specific induction. Mol. Cell. Biol. 13, 1332-1344 (1993).
153. Zhang Y, Rom WN: Regulation of the interleukin-1β (IL-1β) gene by mycobacterial components and lipopolysaccharide is mediated by two nuclear factor-IL6 motifs. Mol. Cell. Biol. 13, 3831-3837 (1993).
154. Coyle-Rink J, Sweet T, Abraham S et al.: Interaction between TGF-β signaling proteins and C/EBP controls basal and Tat-mediated transcription of HIV-1 LTR in astrocytes. Virology 299, 240-247 (2002).
155. Pope R, Mungre S, Liu H, Thimmapaya B: Regulation or TNF-α expression in normal macrophages: the role of C/EBPβ. Cytokine 12, 1171-1181 (2000).
156. Pope RM, Leutz A, Ness SA: C/EBPβ regulation of the tumor necrosis factor-α gene. J. Clin. Invest. 94, 1449-1455 (1994).
157. Zagariya A, Mungre S, Lovis R et al.: Tumor necrosis factor-α gene regulation: enhancement of C/EBPβ-induced activation by c-Jun. Mol. Cell. Biol. 18, 2815-2824 (1998).
158. Piwien-Pilipuk G, MacDougald O, Schwartz J: Dual regulation of phosphorylation and dephosphorylation of C/EBPβ modulate its transcriptional activation and DNA binding in response to growth hormone. J. Biol. Chem. 277, 44557-44565 (2002).
159. Basak C, Pathak SK, Bhattacharyya A et al.: NF-κB- and C/ EBPP-driven interleukin-1β gene expression and PAK1-mediated caspase-1 activation play essential roles in interleukin-1β release from Helicobacter pylori lipopolysaccharide-stimulated macrophages. J. Biol. Chem. 280, 4279-4288 (2005).
160. Sekine O, Nishio Y, Egawa K et al.: Insulin activates CCAAT/ enhancer binding proteins and proinflammatory gene expression through the phosphatidylinositol 3-kinase pathway in vascular smooth muscle cells. J. Biol. Chem. 277, 36631-36639 (2002).
161. Bretz JD, Williams SC, Baer M, Johnson PF, Schwartz RC: C/EBP-related protein 2 confers lipopolysaccharide-inducible expression of interleukin 6 and monocyte chemoattractant protein 1 to a lymphoblastic cell line. Proc. Natl Acad. Sci. USA 91, 7306-7310 (1994).
162. Spooner CJ, Guo X, Johnson PF, Schwartz RC: Differential roles of C/ EBPβ regulatory domains in specifying MCP-1 and IL-6 transcription. Mol. Immunol. 44, 1384-1392 (2007).
163. Cupp C, Taylor JP, Khalili K, Amini S: Evidence for stimulation of the transforming growth factor β1 promoter by HIV-1 Tat in cells derived from CNS. Oncogene 8, 2231-2236 (1993).
164. Sawaya BE, Thatikunta P, Denisova L et al.: Regulation of TNF-α and TGFβ-1 gene transcription by HIV-1 Tat in CNS cells. J. Neuroimmunol. 87, 33-42 (1998).
165. Thatikunta P, Sawaya BE, Denisova L et al.: Identification of a cellular protein that binds to Tat-responsive element of TGF β-1 promoter in glial cells. J. Cell Biochem. 67, 466-477 (1997).
166. Heldin CH, Miyazono K, ten Dijke P: TGF-β signalling from cell membrane to nucleus through Smad proteins. Nature 390, 465-471 (1997).
167. Piek E, Heldin CH, ten Dijke P: Specificity, diversity, and regulation in TGF-β superfamily signaling. FASEB J. 13, 2105-2124 (1999).
168. Grant C, Barmak K, Alefantis T et al.: Human T-cell leukemia virus type I and neurologic disease: events in bone marrow, peripheral blood, and central nervous system during normal immune surveillance and neuroinflammation. J. Cell. Physiol. 190, 133-159 (2002).
169. Hollsberg P, Hafler DA: Seminars in medicine of the Beth Israel Hospital, Boston. Pathogenesis of diseases induced by human lymphotropic virus type I infection. N. Engl. J. Med. 328, 1173-1182 (1993).
170. Nakamura T: Immunopathogenesis of HTLV-I-associated myelopathy/tropical spastic paraparesis. Ann Med 32, 600-607 (2000).
171. Yoshida M: Multiple viral strategies of HTLV-1 for dysregulation of cell growth control. Annu. Rev. Immunol. 19, 475-496 (2001).
172. Kashanchi F, Brady JN: Transcriptional and post-transcriptional gene regulation of HTLV-1. Oncogene 24, 5938-5951 (2005).
173. Kimzey AL, Dynan WS: Specific regions of contact between human T-cell leukemia virus type I Tax protein and DNA identified by photocross-linking. J. Biol. Chem. 273, 13768-13775 (1998).
174. Lenzmeier BA, Giebler HA, Nyborg JK: Human T-cell leukemia virus type 1 Tax requires direct access to DNA for recruitment of CREB binding protein to the viral promoter. Mol. Cell. Biol. 18, 721-731 (1998).
175. Lemasson I, Polakowski NJ, Laybourn PJ, Nyborg JK: Transcription factor binding and histone modifications on the integrated proviral promoter in human T-cell leukemia virus-I-infected T-cells. J. Biol. Chem. 277, 49459-49465 (2002).
176. Lu H, Pise-Masison CA, Fletcher TM et al.: Acetylation of nucleosomal histones by p300 facilitates transcription from tax-responsive Imman T-cell leukemia virus type 1 chromatin template. Mol. Cell. Biol. 22, 4450-4462 (2002).
177. Gachon F, Peleraux A, Thebault S et al.: CREB-2, a cellular CRE-dependent transcription repressor, functions in association with Tax as an activator of the human T-cell leukemia virus type 1 promoter. J. Virol. 72, 8332-8337 (1998).
178. Gachon F, Thebault S, Peleraux A, Devaux C, Mesnard JM: Molecular interactions involved in the transactivation of the human T-cell leukemia virus type 1 promoter mediated by Tax and CREB-2 (ATF-4). Mol. Cell. Biol. 20, 3470-3481 (2000).
179. Yin MJ, Paulssen E, Seeler J, Gaynor RB: Chimeric proteins composed of Jun and CREB define domains required for interaction with the human T-cell leukemia virus type 1 Tax protein. J. Virol. 69, 6209-6218 (1995).
180. Grant C, Nonnemacher M, Jain P et al.: CCAAT/enhancer-binding proteins modulate human T-cell leukemia virus type 1 long terminal repeat activation. Virology 348, 354-369 (2006).
181. Hivin P, Gaudray G, Devaux C, Mesnard JM: Interaction between C/EBPβ and Tax down-regulates human T-cell leukemia virus type I transcription. Virology 318, 556-565 (2004).
182. Li-Weber M, Giaisi M, Krammer PH: Roles of CCAAT/enhancer-binding protein in transcriptional regulation of the human IL-5 gene. Eur J. Immunol. 31, 3694-3703 (2001).
183. Boche D, Khatissian E, Gray F et al.: Viral load and neuropathology in the SIV model. J. Neurovirol. 5, 232-240 (1999).
184. Nonnemacher MR, Hogan TH, Quiterio S et al.: Identification of binding sites for members of the CCAAT/enhancer binding protein transcription factor family in the Simian Immunodeficiency Virus long terminal repeat. Biomed. Pharmacother. 77, 34-40 (2003).
185. Barber SA, Herbst DS, Bullock BT, Gama L, Clements JE: Innate immune responses and control of acute simian immunodeficiency virus replication in the central nervous system. J. Neurovirol. 10(Suppl. 1), 15-20 (2004).
186. Barber SA, Gama L, Dudaronek JM et al.: Mechanism for the establishment of transcriptional HIV latency in the brain in a simian immunodeficiency virus-macaque model. J. Infect. Dis. 193, 963-970 (2006).
187. Weed MR, Hienz RD, Brady JV et al.: Central nervous system correlates of behavioral deficits following simian immunodeficiency virus infection. J. Neurovirol. 9, 452-464 (2003).
188. Flaherty MT, Hauer DA, Mankowski JL, Zink MC, Clements JE: Molecular and biological characterization of a neurovirulent molecular clone of simian immunodeficiency virus. J. Virol. 71, 5790-5798 (1997).
189. Mankowski JL, Flaherty MT, Spelman JP et al.: Pathogenesis of simian immunodeficiency virus encephalitis: viral determinants of neurovirulence. J. Virol. 71, 6055-6060 (1997).
190. Mohan M, Aye PP, Borda JT, Alvarez X, Lackner AA: CCAAT/enhancer binding protein β is a major mediator of inflammation and viral replication in the gastrointestinal tract of simian immunodeficiency virus-infected rhesus macaques. Am. J. Pathol. 173, 106-118 (2008).
191. Leroy H, Roumier C, Huyghe P et al.: CEBPA point mutations in hematological malignancies. Leukemia 19, 329-334 (2005).
192. Fuchs O: Growth-inhibiting activity of transcription factor C/ EBPα, its role in haematopoiesis and its tumour suppressor or oncogenic properties in leukaemias. Folia Biol (Praha) 53, 97-108 (2007).
193. Nerlov C: C/EBPα mutations in acute myeloid leukaemias. Nat. Rev. Cancer 4, 394-400 (2004).
194. Verani A, Gras G, Pancino G: Macrophages and HIV-1: dangerous liaisons. Mol. Immunol. 42, 195-212 (2005).